US High-Intensity Sweeteners Market

ID: MRFR/FnB/19722-HCR
200 Pages
Snehal Singh
Last Updated: April 06, 2026
US High Intensity Sweeteners Market Size, Share, Industry Trend & Analysis Research Report: By Product (Sucralose, Stevioside, Acesulfame K, Aspartame, Cyclamate, Glycyrrhizin, Saccharin, Others), By Form (Dry, Liquid), By Category (Artificial, Natural), By Application (Bakery & Confectionery, Beverages, Dairy Products, Dietary Products, Pharmaceuticals, Tabletop Sweeteners, Processed Foods, Other), By End User (Residential, Commercial) and By Distribution Channel (Supermarkets & Hypermarkets, Specialty Stores, Online, Others) - Forecast to 2035.
US High-Intensity Sweeteners Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)7.15%
2024 Market Size$ 630.04 Million
2025 Market Size$ 675.09 Million
2035 Market Size$ 1,346.74 Million
Key Players
Cargill
DuPont
Ajinomoto
Tate & Lyle
Sweeteners Plus
Mitsubishi Corporation
Trends
  • Rising Health Consciousness
  • Innovation in Product Development
  • Regulatory Developments
Opportunities
  • Expansion of the Food and Beverage Sector
  • Growing Demand for Low-Calorie Alternatives
  • Regulatory Support for Low-Calorie Sweeteners
Summary Table of Contents Segmentation Download PDF
  1. 1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. 1.1 EXECUTIVE SUMMARY
      1. 1.1.1 Market Overview
      2. 1.1.2 Key Findings
      3. 1.1.3 Market Segmentation
      4. 1.1.4 Competitive Landscape
      5. 1.1.5 Challenges and Opportunities
      6. 1.1.6 Future Outlook
  2. 2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. 2.1 MARKET INTRODUCTION
      1. 2.1.1 Definition
      2. 2.1.2 Scope of the study
        1. 2.1.2.1 Research Objective
        2. 2.1.2.2 Assumption
        3. 2.1.2.3 Limitations
    2. 2.2 RESEARCH METHODOLOGY
      1. 2.2.1 Overview
      2. 2.2.2 Data Mining
      3. 2.2.3 Secondary Research
      4. 2.2.4 Primary Research
        1. 2.2.4.1 Primary Interviews and Information Gathering Process
        2. 2.2.4.2 Breakdown of Primary Respondents
      5. 2.2.5 Forecasting Model
      6. 2.2.6 Market Size Estimation
        1. 2.2.6.1 Bottom-Up Approach
        2. 2.2.6.2 Top-Down Approach
      7. 2.2.7 Data Triangulation
      8. 2.2.8 Validation
  3. 3 SECTION III: QUALITATIVE ANALYSIS
    1. 3.1 MARKET DYNAMICS
      1. 3.1.1 Overview
      2. 3.1.2 Drivers
      3. 3.1.3 Restraints
      4. 3.1.4 Opportunities
    2. 3.2 MARKET FACTOR ANALYSIS
      1. 3.2.1 Value chain Analysis
      2. 3.2.2 Porter's Five Forces Analysis
        1. 3.2.2.1 Bargaining Power of Suppliers
        2. 3.2.2.2 Bargaining Power of Buyers
        3. 3.2.2.3 Threat of New Entrants
        4. 3.2.2.4 Threat of Substitutes
        5. 3.2.2.5 Intensity of Rivalry
      3. 3.2.3 COVID-19 Impact Analysis
        1. 3.2.3.1 Market Impact Analysis
        2. 3.2.3.2 Regional Impact
        3. 3.2.3.3 Opportunity and Threat Analysis
  4. 4 SECTION IV: QUANTITATIVE ANALYSIS
    1. 4.1 Healthcare, BY Type (USD Million)
      1. 4.1.1 Sucralose
      2. 4.1.2 Stevioside
      3. 4.1.3 Acesulfame K
      4. 4.1.4 Aspartame
      5. 4.1.5 Cyclamate
      6. 4.1.6 Glycyrrhizin
      7. 4.1.7 Saccharin
      8. 4.1.8 Others
    2. 4.2 Healthcare, BY Form (USD Million)
      1. 4.2.1 Dry
      2. 4.2.2 Liquid
    3. 4.3 Healthcare, BY Category (USD Million)
      1. 4.3.1 Artificial
      2. 4.3.2 Natural
    4. 4.4 Healthcare, BY Application (USD Million)
      1. 4.4.1 Bakery & Confectionery
      2. 4.4.2 Beverages
      3. 4.4.3 Dairy Products
      4. 4.4.4 Dietary Products
      5. 4.4.5 Pharmaceuticals
      6. 4.4.6 Tabletop Sweeteners
      7. 4.4.7 Processed Foods
      8. 4.4.8 Other
    5. 4.5 Healthcare, BY End User (USD Million)
      1. 4.5.1 Residential
      2. 4.5.2 Commercial
    6. 4.6 Healthcare, BY Distribution Channel (USD Million)
      1. 4.6.1 Supermarkets & Hypermarkets
      2. 4.6.2 Specialty Stores
      3. 4.6.3 Online
      4. 4.6.4 Others
  5. 5 SECTION V: COMPETITIVE ANALYSIS
    1. 5.1 Competitive Landscape
      1. 5.1.1 Overview
      2. 5.1.2 Competitive Analysis
      3. 5.1.3 Market share Analysis
      4. 5.1.4 Major Growth Strategy in the Healthcare
      5. 5.1.5 Competitive Benchmarking
      6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
      7. 5.1.7 Key developments and growth strategies
        1. 5.1.7.1 New Product Launch/Service Deployment
        2. 5.1.7.2 Merger & Acquisitions
        3. 5.1.7.3 Joint Ventures
      8. 5.1.8 Major Players Financial Matrix
        1. 5.1.8.1 Sales and Operating Income
        2. 5.1.8.2 Major Players R&D Expenditure. 2023
    2. 5.2 Company Profiles
      1. 5.2.1 Cargill (US)
        1. 5.2.1.1 Financial Overview
        2. 5.2.1.2 Products Offered
        3. 5.2.1.3 Key Developments
        4. 5.2.1.4 SWOT Analysis
        5. 5.2.1.5 Key Strategies
      2. 5.2.2 DuPont (US)
        1. 5.2.2.1 Financial Overview
        2. 5.2.2.2 Products Offered
        3. 5.2.2.3 Key Developments
        4. 5.2.2.4 SWOT Analysis
        5. 5.2.2.5 Key Strategies
      3. 5.2.3 Ajinomoto (JP)
        1. 5.2.3.1 Financial Overview
        2. 5.2.3.2 Products Offered
        3. 5.2.3.3 Key Developments
        4. 5.2.3.4 SWOT Analysis
        5. 5.2.3.5 Key Strategies
      4. 5.2.4 Tate & Lyle (GB)
        1. 5.2.4.1 Financial Overview
        2. 5.2.4.2 Products Offered
        3. 5.2.4.3 Key Developments
        4. 5.2.4.4 SWOT Analysis
        5. 5.2.4.5 Key Strategies
      5. 5.2.5 Sweeteners Plus (US)
        1. 5.2.5.1 Financial Overview
        2. 5.2.5.2 Products Offered
        3. 5.2.5.3 Key Developments
        4. 5.2.5.4 SWOT Analysis
        5. 5.2.5.5 Key Strategies
      6. 5.2.6 Mitsubishi Corporation (JP)
        1. 5.2.6.1 Financial Overview
        2. 5.2.6.2 Products Offered
        3. 5.2.6.3 Key Developments
        4. 5.2.6.4 SWOT Analysis
        5. 5.2.6.5 Key Strategies
      7. 5.2.7 NutraSweet (US)
        1. 5.2.7.1 Financial Overview
        2. 5.2.7.2 Products Offered
        3. 5.2.7.3 Key Developments
        4. 5.2.7.4 SWOT Analysis
        5. 5.2.7.5 Key Strategies
      8. 5.2.8 Südzucker AG (DE)
        1. 5.2.8.1 Financial Overview
        2. 5.2.8.2 Products Offered
        3. 5.2.8.3 Key Developments
        4. 5.2.8.4 SWOT Analysis
        5. 5.2.8.5 Key Strategies
    3. 5.3 Appendix
      1. 5.3.1 References
      2. 5.3.2 Related Reports
  6. 6 LIST OF FIGURES
    1. 6.1 MARKET SYNOPSIS
    2. 6.2 US MARKET ANALYSIS BY TYPE
    3. 6.3 US MARKET ANALYSIS BY FORM
    4. 6.4 US MARKET ANALYSIS BY CATEGORY
    5. 6.5 US MARKET ANALYSIS BY APPLICATION
    6. 6.6 US MARKET ANALYSIS BY END USER
    7. 6.7 US MARKET ANALYSIS BY DISTRIBUTION CHANNEL
    8. 6.8 KEY BUYING CRITERIA OF HEALTHCARE
    9. 6.9 RESEARCH PROCESS OF MRFR
    10. 6.10 DRO ANALYSIS OF HEALTHCARE
    11. 6.11 DRIVERS IMPACT ANALYSIS: HEALTHCARE
    12. 6.12 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    13. 6.13 SUPPLY / VALUE CHAIN: HEALTHCARE
    14. 6.14 HEALTHCARE, BY TYPE, 2024 (% SHARE)
    15. 6.15 HEALTHCARE, BY TYPE, 2024 TO 2035 (USD Million)
    16. 6.16 HEALTHCARE, BY FORM, 2024 (% SHARE)
    17. 6.17 HEALTHCARE, BY FORM, 2024 TO 2035 (USD Million)
    18. 6.18 HEALTHCARE, BY CATEGORY, 2024 (% SHARE)
    19. 6.19 HEALTHCARE, BY CATEGORY, 2024 TO 2035 (USD Million)
    20. 6.20 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
    21. 6.21 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
    22. 6.22 HEALTHCARE, BY END USER, 2024 (% SHARE)
    23. 6.23 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Million)
    24. 6.24 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
    25. 6.25 HEALTHCARE, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Million)
    26. 6.26 BENCHMARKING OF MAJOR COMPETITORS
  7. 7 LIST OF TABLES
    1. 7.1 LIST OF ASSUMPTIONS
  8. 7.1.1
    1. 7.2 US MARKET SIZE ESTIMATES; FORECAST
      1. 7.2.1 BY TYPE, 2025-2035 (USD Million)
      2. 7.2.2 BY FORM, 2025-2035 (USD Million)
      3. 7.2.3 BY CATEGORY, 2025-2035 (USD Million)
      4. 7.2.4 BY APPLICATION, 2025-2035 (USD Million)
      5. 7.2.5 BY END USER, 2025-2035 (USD Million)
      6. 7.2.6 BY DISTRIBUTION CHANNEL, 2025-2035 (USD Million)
    2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
  9. 7.3.1
    1. 7.4 ACQUISITION/PARTNERSHIP
  10. 7.4.1

US Healthcare Market Segmentation

Healthcare By Type (USD Million, 2025-2035)

  • Sucralose
  • Stevioside
  • Acesulfame K
  • Aspartame
  • Cyclamate
  • Glycyrrhizin
  • Saccharin
  • Others

Healthcare By Form (USD Million, 2025-2035)

  • Dry
  • Liquid

Healthcare By Category (USD Million, 2025-2035)

  • Artificial
  • Natural

Healthcare By Application (USD Million, 2025-2035)

  • Bakery & Confectionery
  • Beverages
  • Dairy Products
  • Dietary Products
  • US High-Intensity Sweeteners Markets
  • Tabletop Sweeteners
  • Processed Foods
  • Other

Healthcare By End User (USD Million, 2025-2035)

  • Residential
  • Commercial

Healthcare By Distribution Channel (USD Million, 2025-2035)

  • Supermarkets & Hypermarkets
  • Specialty Stores
  • Online
  • Others

Related Reports

No regional reports available for this market.

No country-specific reports available for this market.

Customer Stories

Case Study Cover Image
Case Study

Aerospace & Defense

Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.